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Oligonucleotide conjugates carrying a single functionalized tetrathiafulvalene (TTF) unit linked through a threoninol molecule to
the 3󸀠 or 5󸀠 endswere synthesized together with their complementary oligonucleotides carrying a TTF, pyrene, or pentafluorophenyl
group. TTF-oligonucleotide conjugates formed duplexes with higher thermal stability than the corresponding unmodified
oligonucleotides and pyrene- and pentafluorophenyl-modified oligonucleotides. TTF-modified oligonucleotides are able to bind to
citrate-stabilized gold nanoparticles (AuNPs) and produce stable gold AuNPs functionalized with oligonucleotides. Finally, TTF-
oligoribonucleotides have been synthesized to produce siRNA duplexes carrying TTF units. The presence of the TTF molecule is
compatible with the RNA interference mechanism for gene inhibition.
1. Introduction
There is a current interest in the preparation of oligonu-
cleotide conjugates with functional 𝜋-electron systems since
their 𝜋-𝜋 interaction may provide additional binding energy
without perturbing the specific recognition with the comple-
mentary sequences. Several authors have described aromatic
systems that linked to the 3󸀠 end and 5󸀠 end of oligonu-
cleotides inducing the stabilization of DNA duplexes by 𝜋-𝜋
stacking interactions [1–6].
Recently, we have reported that the introduction of
tetrathiafulvalene (TTF) derivatives at the terminal position
of oligonucleotides induces a high stabilization of the DNA
duplexes. Moreover, depending on the location of the TTF
molecules, a strong aggregation was observed at high salt
concentrations yielding defined spherical nanostructures of
around 190–210 nm of size [7]. TTF molecules are strong
electron-donating molecules which have been used for the
construction of organic conducting materials [8] or as build-
ing blocks in supramolecular chemistry [9].
In this study, we aim to compare the duplex stabiliza-
tion properties of TTF units paired with other donor or
acceptor aromatic molecules. To this end, we synthesized
several oligonucleotides carrying a TTF unit functionalized
with three aliphatic S-butyl groups (Scheme 1) at either 3󸀠
or 5󸀠 ends of the oligonucleotide. Their complementary
oligonucleotide sequences carrying TTF, pyrene, or pentaflu-
orophenyl groups were used to form DNA duplexes with the
donor/acceptor hydrophobic 𝜋-electron systems molecules
at the same or opposite termini of the duplex. The relative
thermal stability of the duplexes was analyzed demonstrating
a distinct behavior of the TTF oligonucleotide conjugates that
is in agreement with the supramolecular properties of TTF.
Moreover, there is an interest in the preparation of stable
gold nanoparticles (AuNPs) functionalized with oligonu-
cleotides. DNA oligomers carrying thiol and dithio groups
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Scheme 1: Preparation of the solids supports and phosphoramidite 4a needed for the assembly of oligonucleotides. (a) R-COOH, EDCI,
1-hydroxybenzotriazole, and DIEA; (b) dimethoxytrityl chloride, DMAP; (c) succinic anhydride, DMAP; (d) hemisuccinate, NH
2
-controlled
pore glass (CPG), TBTU, triethylamine; (e) O-2-cyanoethyl-N,N-diisopropyl chlorophosphoramidite.
are frequently used to functionalize citrate-stabilized gold
nanoparticles [10–12]. The presence of eight thioether func-
tions in TTF units prompted us to investigate the use of TTF-
oligonucleotides for the functionalization of gold nanopar-
ticles. As expected, TTF-modified oligonucleotides are able
to bind to citrate stabilized gold nanoparticles (AuNPs) pro-
ducing stable AuNPs functionalized with oligonucleotides.
Finally, TTF-oligoribonucleotides have been synthesized to
produce siRNA duplexes carrying TTF units. Chemical
modification of the 3󸀠 ends of siRNA is an active area of
research aimed at increasing the stability of modified siRNA
[13, 14] aswell as stabilizing the interaction of siRNAswith the
PAZ domain of RISC [15]. In this work, we demonstrate that
the presence of the TTFmolecule is compatible with the RNA
interference mechanism for gene inhibition, especially if the
TTF unit is located at the 3󸀠 ends of the passenger strand.
2. Materials and Methods
2.1. General Information. All the standard phosphoramidites
and reagents forDNAsynthesis were purchased fromApplied
Biosystems and from Link Technologies. L-threoninol, and
other chemicals were purchased from Sigma-Aldrich and
Fluka. TTF1-threoninol and pyrenyl-threoninol derivatives
were prepared as described [7, 15]. {[4󸀠,5,5󸀠-Tris(butylsulf-
anyl)-2,2󸀠-bi-1,3-dithiol-4-yl]sulfanyl} acetic acid was pre-
pared as described previously [16]. Dry solvents were pur-
chased from Sigma-Aldrich and Fluka and used as received.
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NMR spectra were recorded at 25∘C on Varian Gemini
300MHz, Varian Mercury 400, or Varian Inova 500MHz
spectrometers using deuterated solvents (Unitat de RMN,
Serveis cientificote`cnics de Barcelona). Tetramethylsilane
(TMS) was used as an internal reference (0 ppm) for 1H
spectra recorded in CDCl
3
and the residual signal of the
solvent (77.16 ppm) for 13C-spectra. For CD
2
Cl
2
(53.8 ppm)
and CD
3
OD (49.0 ppm), the residual signal of the solvent
was used as a reference. The external reference for 19F-
spectra was CCl
3
F (0 ppm). Chemical shifts are reported in
part per million (ppm) in the 𝛿 scale, coupling constants
in Hz and multiplicity as follows: s (singlet), d (doublet), t
(triplet), q (quadruplet), m (multiplet), and br (broad signal).
Matrix-assisted laser desorption ionization time-of-flight
(MALDI-TOF) mass spectra were recorded on a Voyager-
DE-RP spectrometer (Applied Biosystems) in negative mode
by using 2,4,6-trihydroxyacetophenone (THAP)/ammonium
citrate (CA) (1 : 1) as matrix and additive resp.). Electrospray
ionization mass spectra (ESI-MS) were recorded on a Micro-
mass ZQ instrumentwith single quadrupole detector coupled
to an HPLC and high-resolution (HR) ESI-MS on an Agilent
1100 LC/MS-TOF instrument (Servei d’Espectrometr´ıa de
Masses, Universitat de Barcelona).
2.2. 3-{[4󸀠,5,5󸀠-Tris(butylsulfanyl)-2,2󸀠-bi-1,3-dithiol-4-yl]sulf-
anyl}propionic Acid. (2-Cyanoethyl)sulfanyl TTF derivative
[17] (1.2 g, 2.2mmol) was dissolved in anhydrous DMF
(50mL) and degassed. A solution of CsOH⋅H
2
O (0.43 g,
2.58mmol, and 1.17 equiv.) in anhydrous MeOH (5mL) was
added. After stirring the reaction mixture at room tempera-
ture for 30min, a suspension of 3-bromopropionic acid (0.5 g,
3.3mmol, and 1.5 equiv.) and freshly annealed K
2
CO
3
(1.8 g,
13mmol, and 5.9 equiv.) in anhydrous DMF (60mL) was
added.The reactionmixture was stirred at room temperature
for 2 h. A solution of 1M HCl (20mL) was added, and the
mixture was extracted with EtOAc (3 × 100mL).The organic
phase was washed with water (3 × 100mL), dried over anhy-
drous MgSO
4
, and concentrated to dryness under reduced
pressure. The crude residue was purified by chromatography
on silica gel (chloroform-methanol 100 : 0 to 90 : 10). The
pure compound was crystallized from dichloromethane and
heptane providing red crystals (1.02 g, 81%). Melting point:
70-71∘C. IR (CHCl
3
): ] = 3512w, 3091 w, 2961 s, 2932 s, 2875 s,
2864m, 2739w, 2656w, 2581 w, 1746w, 1713 s, 1583mbr,
1485w, 1465m, 1458m, 1433m, 1419m, 1381m, 1289m, 1197w,
1100w, 916w, 887m cm−1. UV-Vis (CHCl
3
):𝜆max (log 𝜀) = 264
(4.18), 334 nm (4.14). 1H NMR, 𝛿H (500MHz, CD2Cl2): 0.92
(t, 𝐽 = 7.4Hz, 9H), 1.44 (h, 𝐽 = 7.4Hz, 6H), 1.61 (m, 6H),
2.73 (t, 𝐽 = 6.8Hz, 2H), 2.83 (t, 𝐽 = 7.4, 6H), and 3.05 (t,
𝐽 = 6.8Hz, 2H). 13C NMR, 𝛿C (126MHz, CD2Cl2): 13.91,
22.19, 31.29, 32.37, 34.63, 36.54, 125.69 (=C-SCH
2
), 128.44
(=C-SBu), 175.00 (COOH), and (=CS
2
not detected). ESI
MS: 571 ([M]−), 499 ([M-(C
3
H
5
O
2
)]−). HR ESI MS calcd for
C
21
H
31
O
2
S
8
571.0095, found 571.0093.
2.3. {[4󸀠,5,5󸀠-Tris(butylsulfanyl)-2,2󸀠-bi-1,3-dithiol-4-yl]sulfa-
nyl}-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]propanamide (1b).
A solution of {[4󸀠,5,5󸀠-tris (butylsulfanyl)-2,2󸀠-bi-1,3-dith-
iol-4-yl]sulfanyl}propanoic acid (0.61mmol), L-threoninol
(0.61mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiim-
ide (EDCI) (0.91mmol), hydroxybenzotriazole (HOBt)
(0.91mmol), and diisopropylethylamine (0.91mmol) in
anhydrous DMF (10mL) was prepared under argon.
After stirring the reaction mixture at room temperature
overnight, the mixture was concentrated to dryness under
reduced pressure. The residue was dissolved in toluene and
concentrated to dryness under reduced pressure (3x). The
residue was dissolved in dichloromethane (100mL), and
the organic phase was washed with 10% aqueous NaHCO
3
(2×50mL) and saturated aqueous NaCl (50mL).The organic
phase was dried and concentrated to dryness under reduced
pressure. The resulting TTF2-threoninol derivative was used
in the next step without further purification. The desired
compound was obtained as orange oil (338mg, 83%). TLC
(ethyl acetate) 𝑅
𝑓
= 0.22. 1H NMR, 𝛿H (400MHz, CDCl3):
6.38 (d, 𝐽 = 6.8Hz, 1H, andNH), 4.20 (qd, 𝐽 = 6.4 and 1.6Hz,
1H), 3.88−3.83 (m, 3H), 3.13 (t, 𝐽 = 6.8Hz, 2H), 2.87−2.81
(m, 6H), 2.60 (td, 𝐽 = 6.8Hz and 2.4Hz, 2H), 1.66−1.59
(m, 6H), 1.49−1.40 (m, 6H), 1.23 (d, 𝐽 = 6.4Hz, 3H), and
0.93 (t, 𝐽 = 7.6Hz, 9H). 13C NMR, 𝛿C (100MHz, CDCl3):
171.5 (CO), 130.7 (C), 128.1 (C), 127.9 (C), 125.5 (C), 111.4 (C),
109.4 (C), 69.2 (CH), 65.3 (CH
2
), 55.0 (CH), 36.9 (CH
2
), 36.3
(CH
2
), 36.2 (CH
2
), 32.3 (CH
2
), 32.0 (CH
2
), 21.9 (CH
2
), 21.8
(CH
2
), 20.8 (CH
3
), and 13.8 (CH
3
). HRMS (ESI+): m/z: calc
for C
25
H
41
NO
3
S
8
([M+H]+) 660.0930, found 660.0925.
2.4. N-[(2R,3R)-1,3-Dihydroxybutan-2-yl]-pentafluoroben-
zamide (1c). To a solution of pentafluorobenzoic acid
(1.1mmol) in DMF (2mL) at room temperature, N-hydrox-
ybenzotriazole (1.02mmol) and diisopropylcarbodiimide
(1.02mmol) were added. After stirring the mixture for 5min,
L-threoninol (0.93mmol) was added. The mixture was
stirred at room temperature for 24 h and then quenched
with methanol. The solvent was evaporated under vacuum,
and the residue was purified by flash chromatography
(cyclohexane-CH
2
Cl
2
-MeOH 6 : 3 : 0.5). The desired com-
pound was isolated as a white solid (184mg, 66%). 1H
NMR, 𝛿H (400MHz, CD3OD): 4.10 (dq, 𝐽 = 6.4 and 2.7Hz,
1H), 4.03 (dt, 𝐽 = 6.3 and 2.7Hz, 1H), 3.70 (system ABX,
𝐽
𝐴𝐵
= 10.9Hz, 𝐽
𝐴𝑋
= 6.5Hz, and 𝐽
𝐵𝑋
= 6.2HZ, 2H), 3.30
(m, 1H), and 1.22 (d, 𝐽 = 6.4Hz, 3H). 13C NMR, 𝛿
𝐶
(100Mz,
CDCl
3
): 158.1 (C), 126.9 (C), 126.7 (C), 116.6 (C), 111.4 (C),
69.1 (CH), 64.9 (CH
2
), 54.9 (CH), and 20.4 (CH
3
). 19F NMR,
𝛿F (376MHz, CD3OD): and −144.02 (d, 𝐽 = 19.2Hz, 2F),
−156.3 (t, 𝐽 = 19.9Hz, 1F), −164.6 (m, 2F). HRMS (ESI+):
m/z: calc for C
11
H
11
NO
3
F
5
([M+H]+) 300.0653, found
300.0660.
2.5. N-[(2R,3R)-1-(Bis(4-methoxyphenyl)(phenyl)methoxy)-
3-hydroxybutan-2-yl]-{[4󸀠,5,5󸀠-tris(butylsulfanyl)-2,2󸀠-bi-1,3-
dithol-4-yl]sulfanyl}propanamide (2b). The compound 1b
(0.45mmol) was dried by evaporation of anhydrous acetoni-
trile (ACN) under reduced pressure. The product was dis-
solved in anhydrous pyridine (5mL), and reacted with
4,4󸀠-dimethoxytriphenylmethyl chloride (0.68mmol), diiso-
pro-pyl ethylamine (1.02mmol) and 4-dimethylaminopyri-
dine (0.06mmol, DMAP). After stirring for 6 h at room
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temperature, 4,4󸀠-dimethoxyltritylchloride (0.68mmol),
and DMAP (0.06mmol) dissolved in dry pyridine (5mL)
were added and the mixture was stirred at room temperature
overnight. The reaction was quenched with methanol
(0.5mL) and the solvents were removed under reduced
pressure. The residue was dissolved in toluene (3 × 10mL)
and evaporated to dryness. Then, the resulting material was
dissolved in dichloromethane (100mL), and the organic
phase was washed with 5% aqueous NaHCO
3
(50mL) and
with saturated aqueous NaCl (50mL). The solvent was
evaporated and the residue was purified by chromatography
on neutral aluminium oxide. The product was eluted with
a slow gradient of ethyl acetate from 50 to 100% in hexane
and then from 0 to 10% of methanol in ethyl acetate. The
pure compound was obtained as an orange solid (226mg,
55%). TLC (aluminium oxide) (ethyl acetate-hexane 2 : 1)
𝑅
𝑓
= 0.54. 1H NMR, 𝛿H (400MHz, CDCl3): 7.40−6.82 (m,
13H), 6.20 (d, 𝐽 = 8.8Hz, 1H, NH), 4.09 (qd, 𝐽 = 6.4 and
2.0Hz, 1H), 3.97–3.92 (m, 1H), 3.79 (s, 6H), 3.42 (dd, 𝐽 = 9.6
and 4.4Hz, 1H), 3.30 (dd, 𝐽 = 9.6 and 3.4Hz, 1H), 3,10 (t,
𝐽 = 6.8Hz, 2H), 2.83−2.78 (m, 6H), 2.56 (t, 𝐽 = 6.8Hz, 2H),
1.65–1.56 (m, 6H), 1.47−1.38 (m, 6H), 1.15 (d, 𝐽 = 6.4Hz,
3H), 0.94−0.88 (m, 9H). 13C NMR, 𝛿C (100MHz, CDCl3):
170.9 (CO), 158.8 (C), 144.5 (C), 135.7 (C), 135.5 (C), 130.7
(C), 130.2 (CH), 130.1 (CH), 128.3 (CH), 128.2 (CH), 128.1
(C), 128.0 (C), 127.3 (CH), 125.6 (C), 113.5 (CH), 113.4 (CH),
87.1 (C), 86.7 (CH), 65.3 (CH
2
), 55.5 (CH
3
), 53.8 (CH), 53.8
(CH), 37.0 (CH
2
), 36.3 (CH
2
), 36.2 (CH
2
), 32.2 (CH
2
), 32.0
(CH
2
), 31.9 (CH
2
), 21.9 (CH
2
), 21.8 (CH
2
), 20.2 (CH
3
), 13.8
(CH
3
). HRMS (ESI+):m/z: calc for C
46
H
60
NO
5
S
8
([M+H]+)
962.2237, found 962.2065.
2.6. N-[(2R,3R)-1-(Bis(4-methoxyphenyl)(phenyl)methoxy)-3-
hydroxybutan-2-yl]-pentafluorobenzamide (2c). To a solu-
tion ofN-[(2R,3R)-1,3-dihydroxybutan-2-yl]-pentafluoroben-
zamide (0.53mmol) in pyridine (2.6mL) at 0∘C, diisopropyl-
ethylamine (0.79mmol), 4,4󸀠-dimethoxytritylchloride (0.79
mmol) and 4-dimethylaminopyridine (0.1mmol) were
added. After 15min the mixture was allowed to reach room
temperature, then it was stirred for 24 h, and finally the
reaction was quenched with methanol. The solvent was
evaporated under vacuum, and the residue was purified by
flash chromatography (cyclohexane-EtOAc 3 : 1). The desired
compound was isolated as a yellowish solid (87mg, 27%).
1H NMR, 𝛿H (400Mz, CDCl3): 7.39 (d, 𝐽 = 7.2Hz, 1H),
7.29 (d, 𝐽 = 8.9Hz, 4H), 7.31–7.27 (m, 2H), 7.24–7.18 (m,
1H), 6.83 (d, 𝐽 = 8.9Hz, 4H) 6.69 (d, 𝐽 = 8.6Hz, 1H), 4.13
(d, 𝐽 = 5.4Hz, 1H), 4.15–4.10 (m, 1H), 3.79 (s, 6H), 3.49
(system ABX, 𝐽
𝐴𝐵
= 9.8Hz, 𝐽
𝐴𝑋
= 3.8Hz, and 𝐽
𝐵𝑋
= 3.3Hz,
2H), and 1.20 (d, 𝐽 = 6.4Hz, 3H). 13C NMR, 𝛿C (100Mz,
CDCl
3
): 158.7 (C), 157.6 (C), 144.1 (C), 135.3 (C), 135.0 (C),
129.9 (CH), 129.8 (CH), 129.1 (C), 128.1 (CH), 127.7 (CH),
127.1 (CH), 115.9 (C), 114.7 (C), 113.3 (CH), 113.1 (CH), 87.0
(C), 68.5 (CH
2
), 65.4 (CH), 55.2 (CH
3
), 54.1 (CH), 19.8
(CH
3
). 19F NMR, 𝛿F (376MHz, CDCl3): −140.7 (m, 2F),
−151.2 (t, 𝐽 = 20.7Hz, 1F), and −160.3 (m, 2F). HRMS (ESI+):
m/z: calc for C
32
H
28
NO
5
F
5
Na ([M + Na]+) 624.1779, found
624.1784.
2.7. Functionalization of CPG Solid Supports (3b-3c). The
DMT derivatives (2b-2c) were reacted with succinic anhy-
dride and then incorporated on a long-chain alkylamine-
controlled pore glass support (LCAA-CPG) as follows. The
DMT derivative (0.09mmol) was dried by evaporation with
anhydrous ACN under reduced pressure. The residue was
dissolved in anhydrous pyridine (5mL) under argon. Suc-
cinic anhydride (0.22mmol) and DMAP (0.05mmol) were
dissolved in 1mL of pyridine and added to the solution.
After 4 h of stirring at room temperature, succinic anhydride
(0.22mmol) and DMAP (0.05mmol) were dissolved in 1mL
of pyridine and added to the solution. The reaction mixture
was allowed to react overnight. The solvent was removed
under reduced pressure, and the residue was dissolved in
toluene (3 × 10mL) and evaporated to dryness. The resulting
material was dissolved in dichloromethane (20mL). The
organic phase was washed twice with 10% NaHCO
3
(15mL)
and brine (15mL), dried over MgSO
4
, and evaporated to
dryness. The resulting monosuccinate derivative was used in
the next step without further purification.
Amino-LCAA-CPG (CPG New Jersey, 73𝜇mol amino/g,
300mg) was placed into a polypropylene syringe fitted with
a polypropylene disc and washed sequentially with DMF,
methanol, THF, DCM, and ACN (2 × 5mL).Then, a solution
of the appropriate homosuccinate (44 𝜇mol) and triethy-
lamine (175𝜇mol) in anhydrous ACN (0.5mL) was prepared.
The solution was added to the support, and then a solu-
tion of 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium
tetrafluoroborate (TBTU) (175 𝜇mol) in anhydrous ACN
(300 𝜇L) was added. The mixture was left to react for 1 h. The
support was washed with DMF, methanol, DCM, and ACN
(2×5mL).The degree of functionalizationwas determined by
analysis of theDMT released upon the treatment of an aliquot
of the support with a 3% solution of trichloroacetic acid in
DCM. The coupling procedure was repeated once more if
needed, and the functionality of the resin was determined by
DMTquantification (𝑓 = 32 𝜇mol/g for 3b and 50 𝜇mol/g for
3c, DMT cation, 𝜆max 498 nm, 𝜀 = 71.700M−1 cm−1). Finally,
the solid support was treated with the mixture of Ac
2
O/DMF
(1 : 1, 500𝜇L) to cap free amino groups.
2.8. Oligonucleotide Synthesis (DNA). The unmodified olig-
onucleotide sequences 1 (5󸀠TAG AGG CTC CAT TGC3󸀠),
2 (5󸀠GCA ATG GAG CCT CTA3󸀠), and 8 (5󸀠CGC GAA
TTC GCG3󸀠) were synthesized on a DNA/RNA synthe-
sizer (Applied Biosystems 3400) using 200 nmol scale LV200
polystyrene supports and commercially available chemicals.
The benzoyl (Bz) group was used for the protection of the
amino group of C and A and the isobutyryl (iBu) group for
the protection of G. The coupling yields were >97%. The
last DMT group was removed at the end of the synthesis.
Each solid support was treated with aqueous concentrated
ammonia at 55∘C for 12 h to cleave the products from the
supports and remove the benzoyl and isobutyryl groups.
The mixtures were filtered and ammonia solutions were
evaporated to dryness. Unmodified oligonucleotides were
desalted with Sephadex G-25 (NAP-10 column) and analyzed
by HPLC. Column: XBridge OST C
18
(4.6 × 50mm, 2.5 𝜇m).
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Solvent A: 5% ACN in 100mM triethylammonium acetate
(TEAA) (pH = 7) and solvent B: 70% ACN in 100mM
TEAA (pH = 7). Flow rate: 1mL/min. Conditions: 10min
of linear gradient from 0 to 30% B at room temperature for
oligonucleotides 1 and 2 and at 60∘C for oligonucleotide 8.
The resulting oligomers were analyzed by mass spectrometry
(MALDI-TOF) and UV/Vis spectroscopy and used without
further purification.
Oligonucleotides 3 and 4 (5󸀠TAGAGGCTCCATTGC3󸀠-
TTF1 and 5󸀠GCAATGGAGCCTCTA3󸀠-TTF1, resp.), con-
taining the TTF1modification at the 3󸀠 ends were synthesized
on a 0.5 𝜇mol scale using the solid support functionalized
with the TTF1 derivative and the oligonucleotide sequence
5 (TTF1-5󸀠GCAATGGAGCCTCTA3󸀠), containing the modi-
fication at the 5󸀠 ends, was synthesized on a 200 nmol scale
employing LV200 polystyrene supports using the TTF-1-
phosphoramidite as described [7].
Oligonucleotides 6 and 7 (5󸀠TAGAGGCTCCATTGCX3󸀠)
and 9 and 10 (5󸀠CGCGAATTCGCGX3󸀠), X being the pyrenyl
(PYR), and the 2,3,4,5,6-pentafluorophenyl (PFP), respec-
tively, were synthesized on a 1𝜇mol scale using the corre-
sponding solid support functionalized with the appropriate
threoninol derivative prepared as described [15]. The syn-
theses were carried out as described above removing the
last DMT group at the end of the synthesis. In this case
only a 0.2𝜇mol of each solid support was treated with
aqueous concentrated ammonia at 55∘C for 12 h.The resulting
oligonucleotides were desalted with Sephadex G-25 (NAP-
10 column) and purified by HPLC. Column: XBridge OST
C
18
semipreparative column (10 × 50mm, 2.5𝜇m). Flow
rate: 3mL/min. Conditions: 10min of linear gradient from
0 to 30% of B at room temperature for oligonucleotides 6
and 7 and at 60∘C for oligonucleotides 9 and 10. The pure
fractions were combined and evaporated to dryness. The
purified oligonucleotides were analyzed by HPLC. Column:
XBridge OSTC
18
(4.6×50mm, 2.5 𝜇m). Flow rate: 1mL/min.
Conditions: 10min of linear gradient from 0 to 30% of B at
room temperature for oligonucleotides 6 and 7 and at 60∘C
for oligonucleotides 9 and 10. The resulting oligomers were
analyzed by mass spectrometry (MALDI-TOF) and UV/Vis
spectroscopy as well. The yields obtained ranged from 25 to
41%.
2.9. Oligoribonucleotide (RNA) Synthesis. Theunmodified 21-
nucleotide RNA sequences 11 (5󸀠aucugaagaaggagaaaaaTT3󸀠),
12 (5󸀠uuuuucuccuucuucagauTT3󸀠), 13 (5󸀠gcuacagagaaaucu-
cgauTT3󸀠), and 14 (5󸀠aucgagauuucucuguagcTT3󸀠) were syn-
thesized on a DNA/RNA synthesizer (Applied Biosystems
3400) using 200 nmol scale LV200 polystyrene supports,
2󸀠-TBDMS phosphoramidites, thymidine phosphoramidites,
and commercially available chemicals. Guanosine was pro-
tected with the dimethylaminomethylidene group, cytidine
was protected with the acetyl group, and adenosine with
the benzoyl group. The last DMT group was left at the
end of the synthesis. Each solid support was treated with
a mixture of aqueous concentrated ammonia and ethanol
(3 : 1) at 55∘C for 1 h to cleave the products from the supports
and remove the base protecting groups. The mixtures were
filtered, and the solutions were evaporated to dryness. Then,
a mixture of N-methylpyrrolidone (NMP, 461 𝜇L), triethy-
lamine (TEA, 232 𝜇L), and triethylamine trihydrofluoride
(TEA⋅3HF, 307 𝜇L) was prepared, and each dried sample
was treated with 250𝜇L of the mixture for 2 h 30min. at
65∘C. Once the samples reached room temperature, 1.75mL
of a Tris Buffer solution (Glen-Pak RNA Quenching Buffer)
was, added and the oligonucleotides were purified with car-
tridges, (Glen-Pak RNA cartridge purification), following the
procedure described by the manufacturer. The deprotected
oligonucleotides were desalted with Sephadex G-25 (NAP-
10 column) and analyzed by HPLC. Column: XBridge OST
C
18
(4.6 × 50mm, 2.5 𝜇m). Flow rate: 1mL/min. Conditions:
10min of linear gradient from 0 to 30% of B. The resulting
oligomers were analyzed by mass spectrometry (MALDI-
TOF) and UV/Vis spectroscopy (data not shown) and used
without further purification. The yields obtained after car-
tridge purification ranged from 29 to 40%.
Oligonucleotide sequences 15 (5󸀠aucugaagaaggagaaaa-
aTT3󸀠-TTF2) and 16 (5󸀠uuuuucuccuucuucagauTT3󸀠-TTF2)
(passenger and guide resp.), containing the TTF2 modifi-
cation at the 3󸀠 ends (3b) were synthesized on a 0.5 𝜇mol
scale using the solid support functionalized with the TTF2
derivative. The synthesis was carried out as described above
removing the last DMT group.The cleavage and deprotection
steps were performed as described above using 0.25 𝜇mol of
each solid support. The products were purified by HPLC on
an XBridge OST C
18
semipreparative column (10 × 50mm,
2.5 𝜇m). Flow rate: 3mL/min. Conditions: 3min of linear
gradient from 0 to 9% B, then 1min of linear gradient from
9 to 60% B, then 16min of linear gradient from 60 to 75% B.
The purified oligomers were analyzed by mass spectrometry
(MALDI-TOF), UV/Vis, and HPLC. Column: XBridge OST
C
18
(4.6 × 50mm, 2.5 𝜇m) using the conditions described
above except the flow rate that was 1mL/min. The yields
obtained after HPLC purification ranged from 5 to 8%.
2.10. Melting Experiments Performed with Nonself-Comple-
mentary Oligonucleotides. The melting experiments were
performed in duplicate at 3.3𝜇M of duplex concentration.
The solutions were prepared either in 50mM or in 1M NaCl
and 10mM sodium phosphate buffer (pH = 7). The samples
were heated at 90∘C for 5min, allowed to cool slowly to room
temperature to induce annealing and then kept overnight in a
refrigerator at 4∘C. Melting curves were recorded by heating
the samples with a temperature controller from 15 to 80∘C or
from 15 to 95∘C at a constant rate of 1∘C/min by measuring
the absorbance at 260 nm. When the temperature was below
25∘C, argon was flushed to prevent water condensation on
the cuvettes.The absorption spectra andmelting experiments
(absorbance versus temperature) were recorded in 1 cm path-
length cells. The 𝑇
𝑚
values were calculated with the Meltwin
3.2 software.
2.11. Melting Experiments on Self-Complementary Oligonu-
cleotides. Themelting experiments were performed in dupli-
cate at 6.6𝜇M oligonucleotide concentration as described
above. Melting curves were recorded by heating the samples
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with a temperature controller from 15 to 95∘C at a constant
rate of 1∘C/min by monitoring the absorbance at 260 nm.
2.12. Preparation of Oligonucleotide Gold Nanoparticle Con-
jugates. Citrate stabilized gold nanoparticles (9.7 nm) were
purchased from BBI Life Sciences and used as received. To
prepare the conjugates, 5 nmol of tetrathiafulvalene modified
oligonucleotide (3 or 4) dissolved in 1mL of water was
added to 1mL of the gold nanoparticle solution (9.4 nM).
Themixture was shaken for 16–20 h prior to salt stabilization.
Then, the solution was brought to a final concentration
of 10mM sodium phosphate (pH = 7.2). The mixture was
then allowed to equilibrate for 30min before bringing the
concentration to 0.15M NaCl over a 7 h 30min period in a
stepwise manner (0.05M NaCl increments each 2 h 30min).
The solutions were sonicated for 20 s before each addition
to keep the particles dispersed during the salting procedure.
The salting process was followed by incubation overnight at
room temperature. Finally, to remove all unbound oligonu-
cleotides, the solution was centrifuged at 13,200 rpm for
30min. The supernatant was removed, and the reddish solid
at the bottom of the centrifuge tube was dispersed in 1mL of a
0.15MNaCl, 10mMsodiumphosphate buffer (pH= 7.2).This
procedure was repeated three times.The resulting conjugates
were resuspended in 1mL of a 0.15M NaCl, 10mM sodium
phosphate (pH = 7.2), and 0.1% NaN
3
solution. Then, each
solutionwas analyzed byUV-visible absorption spectroscopy,
(3-AuNP: 7.43 nM and 4-AuNp: 7.75 nM). The extinction
coefficient used was the same as that used for unmodified
nanoparticles (𝜀
520
= 7.6 × 10
7M−1 cm−1, data provided
by the manufacturer). Each solution was then stored in the
fridge (4∘C) prior to use.
2.13. Melting Experiments with Oligonucleotide-Gold Nano-
particle Conjugates. Melting experiments were performed in
duplicate at 3.7 nMof each oligonucleotide gold-nanoparticle
conjugate by mixing 498 𝜇L of 3-AuNp, 477 𝜇L of 4-AuNp,
and 25 𝜇L of the 0.15M NaCl and 10mM sodium phosphate
buffer. The samples were heated at 90∘C for 5min, allowed
to cool slowly to room temperature to induce annealing and
then kept in a refrigerator at 4∘C for 48 h. The solutions
were sonicated for 20 s before the melting experiment to
keep the particles dispersed. Melting curves were recorded
by heating the samples with a temperature controller from 15
to 95∘C at a constant rate of 1∘C/min and when monitoring
the absorbance at 523 nm. During the experiment, when the
temperature was below 25∘C, argon was flushed to prevent
water condensation on the cuvettes. 𝑇
𝑚
values were deter-
mined from the maxima or the minima of the first derivative
of the curves, calculated with the Origin 8.0 software.
2.14. Cell Culture. HeLa cells were grown at 37∘C in Dul-
becco’s modified Eagle’s medium (DMEM, GIBCO) supple-
mented with 10% fetal bovine serum (FBS) in a humidified
atmosphere consisting of 5%CO
2
and 95% air. Cells were reg-
ularly passaged tomaintain exponential growth. A day before
transfection, at 50–80% confluency, cells were trypsinized
and diluted with fresh medium (∼1 × 105 cells/mL) and
transferred to 24-well plates (1mL/plate). Four hours before
transfection the medium was removed, and 500𝜇L of fresh
mediumwas added. Two luciferase plasmids, firefly luciferase
(pGL3) and Renilla luciferase (pRL-TK) from Promega, were
used as control and reporter, respectively. For annealing
of siRNAs, 0.2 𝜇M of each strand was incubated using a
100mM potassium acetate, 30mM HEPES-KOH, and 2mM
magnesium acetate buffer (pH = 7.4). The samples were
heated at 90∘C for 1min, allowed to cool slowly to room
temperature to induce annealing and then kept at 37∘C for
1 hour. Cotransfection of plasmids and siRNAs was carried
outwith Lipofectamine 2000 (Life Technologies) as described
by the manufacturer for adherent cell lines. Then, 100𝜇L
containing the plasmids (1.0𝜇g pGL3, 0.1 𝜇g pRL-TK) and the
corresponding siRNAs (1.8 nM) formulated into liposomes
were applied per well. The final concentration of siRNAs
per well was 0.3 nM. The cells were harvested 20 hours after
transfection and lysed using passive lysis buffer (100𝜇L per
well) according to the instructions of the Dual-Luciferase
Reporter Assay System (Promega).The luciferase activities of
the samples were measured using a MicroLuma Plus LB 96V
Luminometer (Berthold Technologies) with a delay time of
2 s and an integrate time of 10 s. The following volumes were
used: 20𝜇L of sample and 30 𝜇L of each reagent (Luciferase
Assay Reagent II and Stop and Glo Reagent). Ratios of target
to control luciferase were normalized to a buffer control.
The inhibitory effects generated by siRNAs duplexes were
expressed as normalized ratios between the activities of the
reporter Renilla reniformis (RL) and the control Photinus
pyralisGL3 (pGL3) luciferase.The plotted data were averaged
from three independent experiments ± s.d.
3. Results and Discussion
3.1. Synthesis of End-Capped Oligonucleotides. L-threoninol
was selected as a linker to incorporate TTF, pyrene or
pentafluorophenyl moieties into DNA as illustrated in
Scheme 1. Threoninol has been used as a linker to intro-
duce TTF, pyrene, or pentafluorophenyl groups at the ter-
minal positions essentially as described [7, 15, 18]. Two
TTF molecules were used with a methylene of differ-
ence (Scheme 1). The synthesis of the threoninol deriva-
tive of the {[4󸀠,5,5󸀠-tris (butylsulfanyl)-2,2󸀠-bis-1,3-dithiol-
4-yl]sulfanyl}acetic acid (TTF1, [16]) was described previ-
ously [7]. Using a similar protocol, the threoninol deriva-
tive of the {[4󸀠,5,5󸀠-tris(butylsulfanyl)-2,2󸀠-bis-1,3-dithiol-4-
yl]sulfanyl}propionic acid (TTF2) was prepared in good
yields. The threoninol derivative of the pentafluorophenyl
(PFP) was prepared following the protocol described previ-
ously for the threoninol derivative of pyrene (PYR) [15].
Oligonucleotide (DNA and RNA) sequences 1–16 shown
in Table 1 were prepared using a DNA/RNA synthesizer.
For the synthesis of TTF-containing RNA molecules 15 and
16, the TTF2 derivative was selected. As these oligonu-
cleotides will be used in RNA interference experiments
the extra methylene of the propionic acid derivative was
judged to be potentially better in order to separate the TTF
molecule from the RNA sequence as this may influence in
the interaction with RISC [15]. Using standard protocols,
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Table 1: Sequences of DNA and RNA oligonucleotides.
No. Sequence (5󸀠-3󸀠)(a)
1 TAG AGG CTC CAT TGC
2 GCA ATG GAG CCT CTA
3 TAG AGG CTC CAT TGC-TTF1
4 GCA ATG GAG CCT CTA-TTF1
5 TTF1-GCA ATG GAG CCT CTA
6 TAG AGG CTC CAT TGC-PYR
7 TAG AGG CTC CAT TGC-PFP
8 CGC GAA TTC GCG
9 CGC GAA TTC GCG-PYR
10 CGC GAA TTC GCG-PFP
11 auc uga aga agg aga aaa aTT
12 uuu uuc ucc uuc uuc aga uTT
13 gcu aca gag aaa ucu cga uTT
14 auc gag auu ucu cug uag cTT
15 auc uga aga agg aga aaa aTT-TTF2
16 uuu uuc ucc uuc uuc aga uTT-TTF2
(a)TTF: tetrathiafulvalene, PYR: pyrene, PFP: 2,3,4,5,6-pentafluorophenyl.
Base notation: DNA = A, C, and G; and T. RNA = a, g, c, and u.
the desired conjugates were obtained in good yields. The
HPLC profiles and mass spectrometry data are shown as
Supporting Information.
4. Melting Analysis
In a previouswork, we described the effect of the TTF1moiety
linked to the 5󸀠 or 3󸀠 ends of oligonucleotides on the stability
of the correspondingDNAduplexes [7]. Duplexes containing
a TTF1 unit in each strand lead to either aggregation or
strong duplex stabilization depending on the relative position
of the TTF1 units and the concentration of salts. Here we
aimed to study the effect of the presence of the TTF1 unit
on the melting temperatures of duplexes carrying a 𝜋-donor
group such as pyrenyl or a 𝜋-acceptor group like 2,3,4,5,6-
pentafluorobenzyl. Results are summarized in Table 2. The
𝑇
𝑚
of the unmodified duplex (1+ 2) and duplexes containing
a single TTF1 unit or two TTF1 units were included in the
Table for comparison purposes. The melting experiments
performed at 1MNaCl are shown in Figure 1. Interestingly, no
aggregationwas observed under any conditions except for the
duplex 3+4 carrying TTF units in opposite ends as described
in reference [7]. Duplexes 6 + 2 and 7 + 2 carrying a single
pyrenyl or 2,3,4,5,6-pentafluorobenzyl group showed a clear
increase in stability as compared with 1 + 2 (Δ𝑇
𝑚
ranging
between 2.8 and 4.2). Such a change is higher than that
observed at the TTF1 duplexes 1 + 4 and 3 + 2 (Δ𝑇
𝑚
ranging
between 0.8 and 2.8, Table 2).Therefore, the stabilization was
slightly higher in the case of the pyrene-modified duplex
6 + 2 probably owing to an end-capping mechanism [1–6].
Duplexes 6+4 and 7+4 comprising both theTTF1 unit and the
pyrenyl or 2,3,4,5,6-pentafluorobenzyl group at the opposite
ends maintained the degree of stabilization (Δ𝑇
𝑚
ranging
between 4.9 and 5.4), which was found at the duplexes 6 + 2
and 7 + 2 containing the aromatic moieties alone. When
the TTF1 unit and the pyrenyl or 2,3,4,5,6-pentafluorobenzyl
groups were placed at the same end of the duplexes 6 + 5 and
7 + 5, a similar stability was observed (Δ𝑇
𝑚
ranging between
2.8 and 4.9) than in the previous case of 6 + 2 and 7 + 2
(Δ𝑇
𝑚
ranging between 2.8 and 4.2). In the same conditions
the duplex having two TTF1 units at the same end (3 + 4) had
the highest increase on melting temperature (Δ𝑇
𝑚
10.9 and
18.8). This indicates the strong interaction between two TTF
molecules.
In addition, we studied the effect on the thermal sta-
bility of the duplexes carrying two pyrenyl groups or two
2,3,4,5,6-pentafluorobenzyl groups placed at opposite ends
of a duplex. To this end, we synthesized the unmodified
self-complementary oligonucleotides 8 and the modified
self-complementary oligonucleotides 9 (a pyrenyl group at
the 3󸀠 ends) and 10 (a 2,3,4,5,6-pentafluorobenzyl group at
the 3󸀠 ends). Results are summarized in Table 2. At low
salt concentration (50mM NaCl), a broad transition was
observed that can be due to the presence of two tran-
sitions: the duplex to hairpin transition followed by the
denaturation of the hairpin as described in a similar system
[19] (Figure S5, C, see Supplementary Material available
online at http://dx.doi.org/10.1155/2013/650160). At high salt
concentration (1M NaCl), a clear transition was observed.
Previously, if TTF1 was present at the end of this sequence
the formation of spherical aggregates was observed [7]. But
now, with PYR and PFP groups, we did not observe the
formation of any aggregate. So, the formation of aggregates is
a particular property of oligonucleotides bearing TTF units.
When two PYR groups or two PFP groups were placed at
opposite ends of the duplexes 9+9 and 10+10, we observed a
clear increase in stability as compared with the nonmodified
duplex (Δ𝑇
𝑚
= 5.1 for the duplex with two pyrenyl units
and 3.5∘C for the duplex containing two PFP units). Again
we observed a higher stabilization in the case of the pyrene-
modified duplex 9+ 9 probably owing to the aforementioned
end-capping mechanism [1–6].
4.1. Gold Nanoparticle Functionalization with TTF1 Oligonu-
cleotides. In addition, we studied the functionalization of
gold nanoparticles with oligonucleotides containing the
TTF1 modification. As oligonucleotides carrying thiol and
dithio groups are used to functionalize citrate-stabilized gold
nanoparticles [10–12], we consider that the presence of several
thioether functions in TTF will be also useful for anchoring
TTF-oligonucleotides onto the surface of gold nanoparticles.
For this purpose oligonucleotides 3 and its complementary
4 carrying a TTF1 modification at the 3󸀠 ends were used.
Immobilization of the modified oligonucleotides on 10 nm
citrate-stabilized gold nanoparticles was carried out using
previously described protocols that consists in the addition of
the TTF-oligonucleotides to the AuNp suspension followed
by slow increase of the salt concentration to reach 0.15M
NaCl [11]. The resulting material is then centrifuged, and the
excess of TTF-oligonucleotide is washed out. The resulting
functionalized gold nanoparticles were characterized by UV-
vis spectroscopy (Figure 2(a)). After modification, only a
small shift in the surface plasmon band was observed (from
𝜆max 519 to 522 for 2-AuNp and from 𝜆max 519 to 523 for
3-AuNp). The effect of the TTF1-modified oligonucleotides
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Table 2: Melting temperatures of duplexes carrying pyrenyl (PYR), 2,3,4,5,6-pentafluorophenyl (PFP), or tetrathiafulvalene (TTF1) units.
Oligonucleotides 50mM 𝑇
𝑚
(∘C) (Δ𝑇
𝑚
)(b) 1M 𝑇
𝑚
(∘C) (Δ𝑇
𝑚
)(b)
NaCl(a) NaCl(a)
1 + 2 Duplex 55.8 (0) Duplex 67.4 (0)
1 + 4 TTF1 Duplex 58.6 (2.8) Duplex 69.5 (2.1)
3 + 2
TTF1
Duplex 57.2 (1.4) Duplex 68.2 (0.8)
3 + 4
TTF1
TTF1 Duplex 58.9 (3.1) Aggregate —
3 + 5
TTF1
TTF1 Duplex 66.7 (10.9) Duplex 86.2 (18.8)
6 + 2 PYR Duplex 60.0 (4.2) Duplex 71.5 (4.1)
7 + 2
PFP
Duplex 58.3 (3.0) Duplex 70.2 (2.8)
6 + 4
PYRTTF1 Duplex 60.9 (5.1) Duplex 72.8 (5.4)
7 + 4
PFP
TTF1 Duplex 60.7 (4.9) Duplex 72.6 (5.2)
6 + 5
PYR
TTF1 Duplex 60.2 (4.4) Duplex 72.3 (4.9)
7 + 5
PFP
TTF1 Duplex 58.6 (2.8) Duplex 71.0 (3.6)
8 Duplex Broad Duplex 62.7 (0)
9
PYR
PYR Duplex Broad Duplex 67.8 (5.1)
10
PFP
PFP Duplex Broad Duplex 66.2 (3.5)
(a)The shape of the UV spectra: “Duplex” indicates that a standard UV-vis spectrum of a duplex was observed and “Aggregate” indicates that a broad UV-vis
spectrum with a large scattering was measured. (b)Δ𝑇
𝑚
= 𝑇
𝑚
of a modified duplex minus 𝑇
𝑚
of an unmodified duplex under otherwise the same conditions.
The arrows indicate the oligonucleotide orientation 5󸀠→ 3󸀠. Broad indicates a broad transition (supporting information. Figure S5).
on the stability of the conjugates was investigated following
procedures described in the literature [20]. Each conju-
gate was treated with a DTT solution (10mM) at 40∘C
and left to aggregate. Stability was evaluated by measuring
the increment of absorbance at 675 nm that resulted from
gold nanoparticle aggregation. The half-time 𝑡
1/2
(the time
required to reach half the value for complete aggregation)
was less than 1min (data not shown), similar to other
nanoparticles functionalized with disulfide bonds [20].
Moreover, we performed an hybridization assay with gold
nanoparticles functionalized with complementary oligonu-
cleotides. Assuming that the degree of gold nanoparticle
functionalization was similar in each case, we prepared a
3.7 nM solution of each conjugate. The solution was incu-
bated at 4∘C for 48 h. The UV-vis spectrum was mea-
sured after annealing at 15∘C. A plasmon band shift from
522/523 to 525 nm was observed, indicating that there is
plasmonic interaction among the assembled AuNPs in the
annealed solution. Then, a melting experiment at 523 nm
was performed (Figure 2(b)). We observed a decrease in the
absorbance with increasing temperature. We estimated the
melting temperature as the midpoint of the curve (∼61∘C).
TheUV-vis spectrumwasmeasured after themelting analysis
at 85∘C (Figure 2(a)). Comparing with the UV-vis spectrum
recorded before annealing, we observed a small decrease in
the absorbance and a shift of the plasmon band from 525 to
523 nm. This behaviour is different from gold nanoparticles
functionalized with thiol oligonucleotides that have larger
changes in the visible spectra after hybridization [10–12],
but it is in agreement with the small changes in the spectra
observedwith gold-nanoparticles organized byDNAorigami
[21]. For these reasons we believe that hybridization of gold
nanoparticles with TTF-oligonucleotides induces a small
number of contacts between AuNPs and for this reason the
changes in the plasmon band are small. In any case, the
stability of the DNA-TTF-functionalized gold nanoparticles
is high as we do not observe changes in the aggregation state
of the nanoparticles over the time.
4.2. Inhibition of the Luciferase Expression by siRNAsModified
with TTF2 Units. The presence of aromatic groups at the 3󸀠
ends of siRNAs has been previously investigated to stabilize
the interactions between the 3󸀠 ends of siRNA and the
hydrophobic pocket of the PAZ domain of RISC [15]. In
addition, aromatic groups at the 3󸀠end of siRNA efficiently
protect siRNA from degradation of exonucleases present in
the serum [15]. For these reasons we wanted to study the
effect of the TTF modification at the 3󸀠end of the siRNA. We
selected the TTF2 modification at the 3󸀠 ends of the duplex
siRNAs, and we analyzed the inhibition of the luciferase gene
in HeLa cell line. As described before, the extra methylene
of the propionic acid derivative was judged to be potentially
better to separate the TTF molecule from the RNA sequence
as this may influence in the interaction with RISC [15].
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Figure 1: Melting curves of unmodified 15mer duplex 1 + 2 and duplexes carrying aromatic groups (a) at opposite sites and (b) at the same
duplex site. (c) Melting curves of unmodified self-complementary duplex 8 and duplexes carrying two pyrene (9) or two pentafluorophenyl
(10) units at opposite sites. Buffer: 1M NaCl, 10mM sodium phosphate buffer, pH = 7.
Theduplexes used in this studywereDUP1 (12+15, passenger
strand modified with TTF2), DUP2 (11 + 16, guide strand
modified with TTF2), and DUP 3 (15 + 16, both strands
modified with TTF2). The siRNAs sequences were designed
to inhibit Renilla reniformis luciferase. In addition, control
experiments were performed with the unmodified duplex
(WT, 11 + 12) and with a scrambled siRNA (SCR, 14 + 15).
The Renilla luciferase inhibitory activity of modified siRNAs
was evaluated using the dual-luciferase assay system after
incubation with the corresponding siRNAs for 20 hours at
0.3 nM siRNAconcentration.The inhibitory effects generated
by siRNAs duplexes were expressed as normalized ratios
between the activities of the reporter Renilla reniformis (RL)
and the control Photinus pyralis GL3 (pGL3) luciferase.
Figure 3 shows the amount of Renilla luciferase produced
after 20 hrs of transfection with 0.3 nM unmodified siRNA
(WT) or 0.3 nM of the same siRNA duplex carrying TTF2 at
the 3󸀠 ends of passenger (DUP1) or guide strand (DUP2) or
modified in both strands (DUP3). A scrambled siRNAduplex
control sequence (Scr) was used as negative control. siRNA
modified with TTF2 at the 3󸀠 ends of the passenger strand
produced an inhibition of the production ofRenilla luciferase
of 60% compared to the negative controls that was less effi-
cient than unmodified siRNA (75% inhibition). By contrast,
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Figure 2: (a) UV-vis absorbance spectra of gold colloid (black), 3-AuNp, 4-AuNp conjugates (red and blue resp.) and 3-AuNp+4-AuNp after
annealing measured at 15∘C (green line) and at 85∘C (pink line). (b) Melting curve of 3-AuNp+4-AuNp measured at 523 nm.
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Figure 3: RNA interference activity of TTF2-modified siRNAs:
DUP 1 (siRNA carrying a TTF2 unit at the 3󸀠-end of passenger
strand), DUP2 (siRNA carrying a TTF2 unit at the 3󸀠-end of the
guide strand) and DUP3 (siRNA carrying a TTF2 unit at both guide
and passenger strands), WT (unmodified siRNA, wild type), Scr
(scrambled siRNA), Bu: buffer alone. Renilla reniformis luciferase
activity (Rr-luc) (target) versus Photinus pyralis pGL3 luciferase
activity (Pp-luc) (control) after 20 hrs incubation of siRNA (0.3 nM)
designed against Renilla gene in transiently transfected Hela cells.
Ratios of target to control were normalized to a buffer control (Bu).
siRNAs containing TTF2 at the 3󸀠 ends of the guide strand or
in both 3󸀠 ends of guide and passenger strands were clearly
less efficient (52–57% inhibition). This result is in agreement
with previous observations on other aromatic derivatives at
the 3󸀠 ends of the guide strand in the inhibition of a luciferase
gene [15]. In general, it can be concluded that the introduction
of TTF at the 3󸀠 ends can be tolerated by the RNAimachinery
only if the passenger strand of an RNA duplex is function-
alized. Although the results were not very promising, the
hydrophobicity of the TTFderivatives can provide some extra
advantage in the preparation of lipid formulations as it has
been described by cholesterol-modified conjugates. Further
work in this direction is needed to preclude the use of the
TTF-modified siRNA in RNA interference.
5. Conclusions
In summary, we described the effect on the hybridization
properties of 5󸀠- or 3󸀠-end-modified oligonucleotides with
several planar aromatic compounds such as tetrathiaful-
valene (TTF), pyrene (PYR), and pentafluorophenyl (PFP)
groups. All these compounds induce the stabilization of DNA
duplexes by end-capping mechanism as the PYR group the
most stabilizing group followed by the PFP and being the
TTF group the less stabilizing in duplexes carrying a single
modification. In contrast when two TTF groups are located at
the same terminus, themodified duplex is highly stabilized as
a result of a strong 𝜋-𝜋 stacking interaction between the two
TTF units. This interaction is less stable with the PYR:TTF
pair and even less with the PFP:TTF pair. When two TTF
groups are located at opposite ends, aggregate formation
occurs, indicating interstrand 𝜋-𝜋 stacking interactions.This
behaviour is only observed in duplexes carrying two TTF
units. All these results show the strong 𝜋-𝜋 stacking interac-
tions between TTF molecules in water, which are visualized
by DNA duplex thermal denaturation experiments.
In addition, TTF-modified oligonucleotides are shown to
be able to interact with gold nanoparticles producing stable
oligonucleotide-TTF-gold nanoparticle conjugates. Finally,
the synthesis and gene inhibitory properties of TTF-modified
siRNAs are described for the first time, showing that the
Journal of Chemistry 11
modification of the 3󸀠 ends of the passenger strand generates
the most active siRNAs derivatives.
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